These findings establish that tumor-induced ICOSL expression on DCs plays a crucial role in promoting CD8+ T-cell activation, suggesting that the enhanced ICOS signaling observed in CCA actively modulates antitumor immune responses. The gene discussed is CD8A; the disease is cholangiocarcinoma.